1. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl J Med,2017
2. Efficacy and safety of degludec versus glargine in type 2 diabetes;Marso;N Engl J Med,2017
3. Lane WS Bailey TS Gerety G Proceedings of the 76th Scientific Sessions of the American Diabetes Association (ADA) 2016 http://app.core-apps.com/tristar_ada16/abstract/e44e3c20f4b9cf62bd1796c12c1571c4
4. Wysham C Bhargava A Chaykin LB Proceedings of the 76th Scientific Sessions of the American Diabetes Association (ADA), 2016 http://www.abstractsonline.com/pp8/#!/4008/presentation/44493